Published in Cancer Weekly, March 11th, 2003
The large multi-institutional trial led by Holcombe E. Grier, MD, of Dana-Farber Cancer Institute and Children's Hospital Boston, showed that the overall survival rate increased from 61% to 72% for Ewing sarcoma patients with localized disease who underwent the experimental six-drug chemotherapy.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.